Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Dr A F Leite 09/03/2020 25 June 2025 The principal activity of the Company during the financial year was that of a holding company. 12506860 2025-03-31 12506860 bus:Director1 2025-03-31 12506860 2024-03-31 12506860 core:CurrentFinancialInstruments 2025-03-31 12506860 core:CurrentFinancialInstruments 2024-03-31 12506860 core:ShareCapital 2025-03-31 12506860 core:ShareCapital 2024-03-31 12506860 core:RetainedEarningsAccumulatedLosses 2025-03-31 12506860 core:RetainedEarningsAccumulatedLosses 2024-03-31 12506860 core:CostValuation 2024-03-31 12506860 core:AdditionsToInvestments 2025-03-31 12506860 core:CostValuation 2025-03-31 12506860 bus:OrdinaryShareClass1 2025-03-31 12506860 bus:OrdinaryShareClass2 2025-03-31 12506860 2024-04-01 2025-03-31 12506860 bus:FilletedAccounts 2024-04-01 2025-03-31 12506860 bus:SmallEntities 2024-04-01 2025-03-31 12506860 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12506860 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12506860 bus:Director1 2024-04-01 2025-03-31 12506860 2023-04-01 2024-03-31 12506860 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 12506860 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 12506860 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 12506860 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12506860 (England and Wales)

AFL HEALTH LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

AFL HEALTH LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

AFL HEALTH LIMITED

BALANCE SHEET

As at 31 March 2025
AFL HEALTH LIMITED

BALANCE SHEET (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Investments 3 1,051 50
1,051 50
Current assets
Debtors 4 68,122 111,765
Cash at bank and in hand 110,551 102,261
178,673 214,026
Creditors: amounts falling due within one year 5 ( 1,018) ( 480)
Net current assets 177,655 213,546
Total assets less current liabilities 178,706 213,596
Net assets 178,706 213,596
Capital and reserves
Called-up share capital 6 150 150
Profit and loss account 178,556 213,446
Total shareholders' funds 178,706 213,596

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of AFL Health Limited (registered number: 12506860) were approved and authorised for issue by the Director on 25 June 2025. They were signed on its behalf by:

Dr A F Leite
Director
AFL HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
AFL HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

AFL Health Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 246 High Street, Exeter, EX4 3NZ, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Dividend income

Dividend income is recognised when the company's right to receive payment has been established.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including the director 0 0

3. Fixed asset investments

Listed investments Investments in associates Total
£ £ £
Cost or valuation before impairment
At 01 April 2024 0 50 50
Additions 1,000 1 1,001
At 31 March 2025 1,000 51 1,051
Carrying value at 31 March 2025 1,000 51 1,051
Carrying value at 31 March 2024 0 50 50

4. Debtors

2025 2024
£ £
Amounts owed by Group undertakings 1,200 1,200
Amounts owed by associates 53,798 103,498
Other debtors 13,124 7,067
68,122 111,765

5. Creditors: amounts falling due within one year

2025 2024
£ £
Amounts owed to associates 1,018 480

6. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
120 Ordinary shares of £ 1.00 each 120 120
30 Ordinary A shares of £ 1.00 each 30 30
150 150

7. Related party transactions

Transactions with the entity's director

2025 2024
£ £
Directors' loan 13,124 7,067

During the year the company advanced £28,038 to the directors, of which £22,000 was repaid. Interest totalling £19 has been charged on the balance at the actual official rate set out by HMRC. At 31 March 2025, £13,124 (2024: £7,067) was due to the company and is repayable on demand.